Literature DB >> 20361361

The role of Pygopus 2 in rat glioma cell growth.

Yu-Ying Chen1, Bo-An Li, Hai-Dong Wang, Xi-Yao Liu, Guo-Wei Tan, Yong-Hui Ma, Shang-Hang Shen, Hong-Wei Zhu, Zhan-Xiang Wang.   

Abstract

Glioma is a common malignant tumor of the human neural system, and Wnt signaling activation is closely connected with glioma malignancy. Pygopus 2 (Pygo2) was recently discovered as a component of the Wnt signaling pathway regulating β-catenin/Tcf dependent transcription. However, the role of Pygo2 in glioma cells has not yet been defined. In the current study, we investigated the role of Pygo2 in rat glioma C6 cells for the first time. Our results showed that over-expression of Pygo2 promoted cell proliferation as well as enhanced cell cycle progression from G₁ to S phase associated with an increase in the expression of the Wnt target gene cyclin D1. In contrast, knockdown of Pygo2 suppressed cell proliferation with cell cycle block from G₁ to S phase and down-regulation of cyclin D1. In addition, the expression of Pygo2 and cyclin D1 in 67 glioma tissue samples was quantified by real-time reverse transcription polymerase chain reaction (RT-PCR) and immunochemistry. The data indicated that tumor grade was significantly associated with over-expression of Pygo2 and cyclin D1. We conclude that Pygo2 is highly expressed in and promotes the growth of glioma cells by an increase in the expression of cyclin D1 to improve G₁/S transition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361361     DOI: 10.1007/s12032-010-9488-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  39 in total

1.  Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.

Authors:  Thomas Kramps; Oliver Peter; Erich Brunner; Denise Nellen; Barbara Froesch; Sandipan Chatterjee; Maximilien Murone; Stephanie Züllig; Konrad Basler
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

Review 2.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 3.  Wnt, stem cells and cancer in the intestine.

Authors:  Daniel Pinto; Hans Clevers
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

4.  Requirement of Pygopus 2 in breast cancer.

Authors:  Phillip G P Andrews; Blue B Lake; Catherine Popadiuk; Kenneth R Kao
Journal:  Int J Oncol       Date:  2007-02       Impact factor: 5.650

Review 5.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

6.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 7.  Minireview: Cyclin D1: normal and abnormal functions.

Authors:  Maofu Fu; Chenguang Wang; Zhiping Li; Toshiyuki Sakamaki; Richard G Pestell
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

View more
  3 in total

1.  Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.

Authors:  Qiuling Li; Yuewei Li; Bingnan Gu; Lei Fang; Pengbo Zhou; Shilai Bao; Lan Huang; Xing Dai
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

2.  Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway.

Authors:  Haidong Wang; Jianhua Fu; Dianshuang Xu; Weiwei Xu; Shiyong Wang; Liu Zhang; Yongsheng Xiang
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

3.  Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.

Authors:  Cefan Zhou; Hongxia Cheng; Wenying Qin; Yi Zhang; Hui Xiong; Jing Yang; Huang Huang; Yefu Wang; Xing-Zhen Chen; Jingfeng Tang
Journal:  Oncotarget       Date:  2017-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.